GO:0061711 tRNA N(6)-L-threonylcarbamoyladenine synthase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0061711 describes the molecular function that attaches a threonylcarbamoyl group to adenine 37 of tRNA, forming the universal modification t6A.
The reaction consumes L-threonylcarbamoyladenylate and produces AMP plus N(6)-L-threonylcarbamoyladenine(37) in tRNA.
t6A is found at position 37 of tRNAs that read ANN codons and is required for efficient and accurate translation.
The synthase belongs to the TsaC/Sua5 family and uses a conserved ATP-pyrophosphate exchange mechanism to activate threonine and bicarbonate.
Loss of t6A synthase activity impairs protein synthesis and has been linked to neurodevelopmental and mitochondrial phenotypes in model organisms.
Chemoproteomic and structural methods are now used to map RNA-modification enzymes and their substrate interactions [1,2].

Description

GO:0061711, tRNA N(6)-L-threonylcarbamoyladenine synthase activity, is a molecular function that installs the threonylcarbamoyl group on adenine 37 of tRNA, generating the hypermodified nucleoside N(6)-L-threonylcarbamoyladenine (t6A). This modification is nearly universal in tRNAs that decode ANN codons and is critical for codon-anticodon interactions and translational fidelity. The enzyme catalyzes the reaction L-threonylcarbamoyladenylate + adenine(37) in tRNA = AMP + N(6)-L-threonylcarbamoyladenine(37) in tRNA, as defined by QuickGO. Researchers study this activity because t6A deficiency perturbs the proteome and has been associated with human disease phenotypes in several systems. Structural and biochemical work has revealed that the synthase uses a conserved fold and a two-step mechanism involving an activated intermediate. Chemoproteomic approaches have further expanded the toolkit for studying RNA-modification enzymes and their interactions.

tRNA N(6)-L-threonylcarbamoyladenine synthase activity At A Glance

GO ID GO:0061711
GO term tRNA N(6)-L-threonylcarbamoyladenine synthase activity
Ontology molecular_function
Synonym N(6)-L-threonylcarbamoyladenine synthase activity; t6A synthase activity
Major function Catalyzes the transfer of a threonylcarbamoyl group to adenine 37 of tRNA to form t6A
Reaction L-threonylcarbamoyladenylate + adenine(37) in tRNA = AMP + N(6)-L-threonylcarbamoyladenine(37) in tRNA
Substrate L-threonylcarbamoyladenylate and adenine(37) in tRNA
Product AMP and N(6)-L-threonylcarbamoyladenine(37) in tRNA
Related activity t6A biosynthesis and tRNA modification

What Is GO:0061711?

In simple terms, GO:0061711 is the enzyme activity that adds a threonylcarbamoyl chemical tag to a specific adenosine in tRNA. The official definition is: Catalysis of the reaction: L-threonylcarbamoyladenylate + adenine(37) in tRNA = AMP + N(6)-L-threonylcarbamoyladenine(37) in tRNA. The activity is also known as N(6)-L-threonylcarbamoyladenine synthase activity or t6A synthase activity. It belongs to the molecular_function ontology aspect and is responsible for producing the t6A modification at position 37 of tRNA.

Why Is tRNA N(6)-L-threonylcarbamoyladenine synthase activity Important in Cell Biology?

GO:0061711 is important because t6A is a universally conserved tRNA modification that directly influences translation efficiency and fidelity. Without this activity, tRNAs that read ANN codons cannot properly stabilize codon-anticodon pairing, leading to ribosomal pausing and proteome imbalance. Because translation is central to cell growth and stress responses, defects in t6A synthase activity can affect development, mitochondrial function, and neuronal survival. Studying this activity also provides a paradigm for understanding how RNA-modifying enzymes recognize their substrates, which is relevant to drug discovery and chemoproteomic profiling [1,2].
t6A is required for accurate decoding of ANN codons during translation.
Loss of t6A synthase activity causes ribosome pausing and protein aggregation in model systems.
t6A modification is conserved from bacteria to humans, making it a tractable research target.
Mutations in t6A pathway genes have been linked to neurodevelopmental disorders.
The synthase is a potential target for antimicrobial and anticancer strategies.
Chemoproteomic probes can identify RNA-modification enzymes and their interactors.
Structural studies of the synthase reveal druggable pockets and substrate-binding residues.
t6A levels can serve as biomarkers of translational stress.

Molecular Mechanism of tRNA N(6)-L-threonylcarbamoyladenine synthase activity

Substrate recognition and activation
In simple terms: The enzyme first grabs threonine and bicarbonate and turns them into an activated intermediate.
The synthase uses ATP to activate L-threonine and bicarbonate, forming L-threonylcarbamoyladenylate, a high-energy intermediate. Structural analysis by NMR shows that the enzyme binds threonine and ATP in a conserved pocket and undergoes conformational changes upon substrate binding. This step is essential for transferring the threonylcarbamoyl group to tRNA.
Transfer to adenine 37 of tRNA
In simple terms: The activated group is then attached to a specific adenine in the tRNA loop.
The enzyme transfers the threonylcarbamoyl moiety from L-threonylcarbamoyladenylate to the N6 position of adenine 37 in tRNA, releasing AMP. This reaction occurs on tRNAs that read ANN codons and requires proper folding of the anticodon loop. The modification stabilizes the U-turn structure of the anticodon loop and enhances codon-anticodon interactions.
Catalytic residues and cofactors
In simple terms: Specific amino acids in the enzyme do the chemistry, and no metal cofactor is strictly required.
Mutational and structural studies have identified conserved residues in the TsaC/Sua5 family that coordinate substrates and stabilize the transition state. Unlike some radical SAM enzymes, t6A synthase does not require iron-sulfur clusters for its core activity. The reaction is driven by ATP hydrolysis and the intrinsic reactivity of the activated intermediate.
Regulation and quality control
In simple terms: The cell adjusts t6A levels according to growth conditions and stress.
t6A synthase activity can be regulated at the level of gene expression and by substrate availability. In bacteria, the synthase is part of an operon with other tRNA-modification genes, allowing coordinated regulation. Quality-control pathways monitor tRNA integrity and can degrade hypomodified tRNAs under stress.

Key Genes Involved in GO:0061711 tRNA N(6)-L-threonylcarbamoyladenine synthase activity

The following genes and proteins are experimentally linked to t6A biosynthesis and the broader tRNA-modification network.
GeneMajor RoleResearch Relevance
TsaC/Sua5t6A synthase that forms L-threonylcarbamoyladenylateCore enzyme for GO:0061711; structural and mechanistic studies
TsaDComponent of the t6A synthesis complex in bacteriaEssential for t6A formation and translation
TsaBAccessory protein in the t6A synthesis complexRequired for efficient t6A modification
TsaEATPase that regulates the t6A complexControls the activity of the synthase complex
YgjDHomolog of TsaD in Gram-positive bacteriaModel for t6A pathway conservation
YeaZHomolog of TsaBSupports t6A synthesis in bacteria
YjeEHomolog of TsaERegulates t6A complex assembly
Sua5Eukaryotic t6A synthaseLinks t6A to translation in eukaryotes
Kae1Eukaryotic homolog of TsaDPart of the EKC complex for t6A synthesis
Bud32Kinase in the EKC complexRegulates t6A synthesis and stress responses
Cgi121Component of the EKC complexModulates t6A synthase activity
Gon7EKC complex subunitRequired for efficient t6A modification
Pcc1EKC complex subunitStabilizes the t6A synthesis machinery
MiaBRadical SAM enzyme for tRNA thiolation/methylationRelated tRNA modification enzyme for comparative studies [5,8]
RimORadical SAM methylthiotransferaseModel for tRNA modification enzymology
MiaAtRNA modification enzymeComparative target for RNA-modifying enzymes
TrmAtRNA methyltransferaseUsed as a control in modification studies

How Is tRNA N(6)-L-threonylcarbamoyladenine synthase activity Regulated?

t6A synthase activity is regulated by substrate availability, complex assembly, and stress-responsive signaling. In bacteria, the tsaC gene is co-transcribed with other tRNA-modification genes, allowing coordinated expression. In eukaryotes, the EKC complex subunits can be phosphorylated, which may alter t6A synthesis under stress. Chemoproteomic profiling has revealed that RNA-modification enzymes are dynamically regulated and can be targeted by small molecules.

tRNA N(6)-L-threonylcarbamoyladenine synthase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
Sua5Neurodevelopmental delayKnockout zebrafish or mouse models
Kae1Mitochondrial dysfunctionPatient-derived fibroblasts with point mutations
TsaCBacterial translation defectsBacterial knockout strains
TsaDCell cycle and growth defectsConditional knockout cell lines
Bud32Stress response and cancerOverexpression and knockdown models
Neurodevelopmental disorders
Defects in t6A synthesis have been associated with neurodevelopmental phenotypes in model organisms, likely due to impaired translation of key neuronal transcripts. Mutations in EKC complex genes can cause developmental delay and microcephaly in humans. Studying GO:0061711 helps clarify how tRNA modification defects contribute to these disorders.
Mitochondrial dysfunction
t6A modification is required for efficient mitochondrial translation, and loss of synthase activity can impair oxidative phosphorylation. This links GO:0061711 to mitochondrial disease phenotypes. Experimental models with reduced t6A levels show respiratory chain defects.
Cancer and translational stress
Cancer cells often have elevated translation rates and may depend on tRNA modifications for survival. Inhibiting t6A synthase activity could selectively sensitize tumors to translational stress. Chemoproteomic tools can help identify inhibitors of RNA-modification enzymes.

From tRNA N(6)-L-threonylcarbamoyladenine synthase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of t6A synthase impair translation?CRISPR knockout of Sua5 in human cells
Which residues are essential for catalysis?Point mutations in TsaC/Sua5
Can t6A levels be restored by knock-in?Knock-in of wild-type or mutant synthase
Where is the synthase localized?Tagged knock-in with fluorescent protein
Does overexpression affect growth?Overexpression of TsaC in bacteria
What proteins interact with the synthase?Affinity purification with tagged knock-in

How to Study the tRNA N(6)-L-threonylcarbamoyladenine synthase activity Process

MethodWhat It MeasuresTypical Application
NMR spectroscopySubstrate binding and conformational changesStructural studies of TsaC/Sua5
X-ray crystallographyThree-dimensional structure of the synthaseActive-site mapping
Ribo-seqRibosome occupancy and pausingTranslation fidelity assays
Mass spectrometryt6A levels in tRNAQuantification of modification
ChemoproteomicsEnzyme-small molecule interactionsDrug target profiling
CRISPR knockoutGene function lossPhenotypic analysis
Western blotProtein expression levelsValidation of knockout/overexpression
Structural analysis by NMR and crystallography
NMR-based structural analysis has been used to determine how the synthase binds substrates and undergoes conformational changes. Crystallography can reveal the active-site architecture and guide inhibitor design.
Chemoproteomic profiling
Chemoproteomic approaches enable the study of RNA-modification enzymes and their interactions with small molecules. These methods can identify off-target effects and guide drug development.
Ribo-seq and translation profiling
Ribo-seq measures ribosome occupancy and can detect pausing caused by loss of t6A. This method is useful for linking GO:0061711 to translational fidelity.
RNA modification mapping
Mass spectrometry and sequencing-based methods can quantify t6A levels in tRNA. These approaches are essential for validating synthase activity in cells.

How CRISPR Can Be Used to Study GO:0061711 tRNA N(6)-L-threonylcarbamoyladenine synthase activity

Knockout

CRISPR knockout of t6A synthase genes such as Sua5 or TsaC can abolish t6A modification and reveal growth and translation defects. These models are useful for studying the essentiality of GO:0061711 in different cell types.

Point Mutation

Point mutations in catalytic residues of the synthase can separate substrate binding from catalysis. Such models help define the precise chemistry of GO:0061711.

Knock-in

Knock-in of tagged or mutant synthase allows localization and interaction studies. This approach can also restore t6A levels in knockout backgrounds.

Overexpression

Overexpression of the synthase can increase t6A levels and may affect translation and stress responses. It is useful for gain-of-function studies.

How EDITGENE Supports tRNA N(6)-L-threonylcarbamoyladenine synthase activity Research

Researchers studying tRNA N(6)-L-threonylcarbamoyladenine synthase activity-related genes often need to determine whether a candidate gene is causally involved in translation, stress responses, or disease phenotypes. EDITGENE provides validated CRISPR models and bioinformatics support to accelerate this work.
Contact EDITGENE today to design your custom CRISPR model for tRNA N(6)-L-threonylcarbamoyladenine synthase activity research.

Frequently Asked Questions About tRNA N(6)-L-threonylcarbamoyladenine synthase activity

It is the enzyme activity defined by GO:0061711 that adds a threonylcarbamoyl group to adenine 37 of tRNA, forming t6A.
Key genes include TsaC/Sua5, TsaD, TsaB, TsaE, and eukaryotic EKC complex subunits such as Kae1 and Bud32.
The reaction is L-threonylcarbamoyladenylate + adenine(37) in tRNA = AMP + N(6)-L-threonylcarbamoyladenine(37) in tRNA.
t6A stabilizes codon-anticodon interactions and is required for efficient and accurate translation.
Defects have been associated with neurodevelopmental disorders and mitochondrial dysfunction.
Common methods include CRISPR knockout, point mutations, Ribo-seq, mass spectrometry, and structural analysis [1,2].
t6A synthase specifically forms t6A, whereas other enzymes such as MiaB and RimO catalyze different tRNA modifications [5,6,8].
Yes, mass spectrometry and sequencing-based methods can quantify t6A in tRNA.
Yes, the Sua5/Kae1 pathway is conserved from bacteria to humans.
EDITGENE offers knockout, point-mutation, knock-in, and overexpression models for t6A pathway genes.

Conclusion

GO:0061711, tRNA N(6)-L-threonylcarbamoyladenine synthase activity, is a central enzyme function for tRNA modification and translation fidelity. Its study bridges structural biology, chemoproteomics, and disease modeling [1,2]. EDITGENE provides comprehensive CRISPR solutions to interrogate this activity in relevant cell models.

References

  1. 1. Dai W et al.. 2023. Chemoproteomic Approaches to Studying RNA Modification-Associated Proteins.. Acc Chem Res 56(19):2726-2739 PMID: 37733063
  2. 2. Harris KA et al.. 2015. NMR-based Structural Analysis of Threonylcarbamoyl-AMP Synthase and Its Substrate Interactions.. J Biol Chem 290(33):20032-43 PMID: 26060251
  3. 5. Pierrel F et al.. 2003. MiaB protein from Thermotoga maritima. Characterization of an extremely thermophilic tRNA-methylthiotransferase.. J Biol Chem 278(32):29515-24 PMID: 12766153
  4. 6. Lee KH et al.. 2009. Characterization of RimO, a new member of the methylthiotransferase subclass of the radical SAM superfamily.. Biochemistry 48(42):10162-74 PMID: 19736993
  5. 8. Hernández HL et al.. 2007. MiaB, a bifunctional radical-S-adenosylmethionine enzyme involved in the thiolation and methylation of tRNA, contains two essential [4Fe-4S] clusters.. Biochemistry 46(17):5140-7 PMID: 17407324
Contact Us
*
*
*
*
How did you hear about us: